APA

Alalaf S. K., Al Tawil N. G., Jawad A. K., Mahmoud M. B., Muhamad B. Q., Abdul Rahman K. H., Sileem S. A., Hassan J. N., Ameen K. M., Mustafa S. A. & Bawadikji A. A. (20210203). Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial. : The journal of obstetrics and gynaecology research.

Chicago

Alalaf Shahla K, Al Tawil Namir G, Jawad Ariana K, Mahmoud Maryam B, Muhamad Bahar Q, Abdul Rahman Khansa H, Sileem Sileem A, Hassan Jinan N, Ameen Khalida M, Mustafa Samira A and Bawadikji AbdulKader A. 20210203. Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial. : The journal of obstetrics and gynaecology research.

Harvard

Alalaf S. K., Al Tawil N. G., Jawad A. K., Mahmoud M. B., Muhamad B. Q., Abdul Rahman K. H., Sileem S. A., Hassan J. N., Ameen K. M., Mustafa S. A. and Bawadikji A. A. (20210203). Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial. : The journal of obstetrics and gynaecology research.

MLA

Alalaf Shahla K, Al Tawil Namir G, Jawad Ariana K, Mahmoud Maryam B, Muhamad Bahar Q, Abdul Rahman Khansa H, Sileem Sileem A, Hassan Jinan N, Ameen Khalida M, Mustafa Samira A and Bawadikji AbdulKader A. Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial. : The journal of obstetrics and gynaecology research. 20210203.